Your tax-deductible donation funds our educational outreach.
Donate
Your tax-deductible donation funds our educational outreach.
Donate
Educating health care professionals and the general public about the therapeutic use of cannabis. Providing educational resources about the therapeutic benefits of cannabis and access to safe and effective cannabis.
Shop through Amazon using the link below to support Patients Out of Time! Amazon donates to Patients Out of Time for every purchase you make.
The conference was the very best example of good science and compassion for patients. Excellent organization!
Our Mission
Patients Out of Time works to re-institute cannabis as a legitimate medicine for use within the United States. Cannabis, under modern research protocols, has been found to be effective in reducing intraocular pressure in glaucoma, reducing nausea and vomiting associated with chemotherapy, stimulating the appetite for persons living with AIDS and suffering from wasting syndrome, controlling spasticity associated with spinal cord injury and multiple sclerosis, treating Dravet Syndrome, reducing the intensity of chronic pain, assisting with treatment for post-traumatic stress disorder, and controlling seizures associated with seizure disorders.
Past Speakers
What to Expect
Dr Raphael Mechoulam
Organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel
Dr. Dustin Sulak
Founder and Medical Director, Integr8 Health Board Member, The Society of Cannabis Clinicians
Amanda Reiman, PhD MSW
Vice President of Community Relations for Flow Kana, a branded cannabis distribution company that works with small farmers in the Emerald Triangle.
Dr. Donald Abrams
Integrative Oncologist, UCSF Osher Center for Integrative Medicine Professor, Department of Medicine
Julie Holland
Psychiatrist specializing in psychopharmacology, with a private practice in New York City. Dr. Holland also provides expert testimony and forensic consultation on a range of drug-related behavior and phenomena, with a focus on PCP and MDMA.
Cathy Jordan
ALS Patient - Catherine Jordan was diagnosed with Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) in 1986 by leading ALS doctors, told she would die within five years. She began using medicinal cannabis in 1989, which she credits with halting the progress od the disease and she is now recognized by the ALS Association as one of the longest living ALS patients.
Brandon Wyatt
Attorney - A decorated army combat solider and disabled veteran, and the National Policy Advisor of the Weed for Warriors Project (WFWP)
Dr Cristina Sánchez
Cristina Sánchez (Madrid, Spain, 1971) graduated in Biology at Madrid Complutense University in 1994. Once graduated, she joined Dr. Manuel Guzmán’s laboratory, where she studied the effect of cannabinoids on lipid and carbohydrate intermediate metabolism first and on cancer cell proliferation later. She obtained her PhD with Honors in Biochemistry and Molecular Biology at Complutense University in 2000.
Manuel Guzmán
Professor of Biochemistry and Molecular Biology at Complutense University of Madrid, member of the Spanish Royal Academy of Pharmacy, and member of the Board of Directors of the International Association for Cannabinoid Medicines.
Dr. Ethan Russo, MD
Board-certified neurologist, psychopharmacology researcher, and former Senior Medical Advisor to GW Pharmaceuticals. He served as study physician to GW Pharmaceuticals for three Phase III clinical trials of Sativex.
Dr Melanie Creagan Dreher
John L. and Helen Kellogg Dean and Professor of the College of Nursing of Rush University in Chicago, Illinois. She is a graduate, magna cum laude, of Long Island University School of Nursing and holds a doctorat3e in anthropology from Teachers College and Columbia University where she completed her dissertation with distinction.
Dr. Dale Gieringer
State Coordinator of California NORML and Co-Founder of California Drug Policy Reform Coalition. Furthermore, he is Co-Founder of Californians for Compassionate Use as well.
Greg Gerdeman, PHD
Neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS)
Dr Juan Sanchez-Ramos
PhD in Pharmacology and Physiology from the University of Chicago and a medical degree (MD) from the University of Illinois. He trained in Neurology at the University of Chicago and as a Fellow in Movement Disorders at the University of Miami. Currently, he is a Professor of Neurology at the University of South Florida in Tampa where he holds the Helen Ellis Endowed Chair for Parkinson’s Disease Research and is Director of the HDSA Center of Excellence for Huntington’s Disease. He is also Medical Director of the non-profit Parkinson Research Foundation based in Sarasota FL.